Care of Patients with Liver Problems Chapter 61 Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. Viral hepatitis – A, B, C, D, E Transmission mode Onset Incubation Laboratory tests Nonsurgical management Follow-up care Plan of care for home Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. Survives on human hands Destroyed by chlorine and high temperatures Fecal – oral route 15 to 50 days incubation time Not life threatening Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. Hand-washing HAV vaccine Havrix Vaqta Avoid contaminated food or water Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. Modes of Transmission Unprotected sex Sharing needles Needle sticks / injuries Blood transfusions Hemodialysis Maternal - fetal Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 25 to 180 days Blood tests confirm disease Carrier Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. Symptoms Anorexia Nausea / Vomiting Fever Fatigue RUQ pain Dark urine Joint pain Jaundice Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. HBV vaccine Engerix-B Recombivax-HB Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. Modes of Transmission Sharing needles Needle sticks / injuries Blood transfusions Tattoo Intranasal cocaine paraphernalia Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 7 weeks Asymptomatic Liver issues occur Causes liver to scar – can progress to cirrhosis Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. Routine laboratory evaluation ELISA – HCV antibodies Within RIBA Been exposed and developed antibodies HCV PCR RNA Active 4 weeks virus and viral load OraQuick HCV Point of care testing Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. Goes along with HBV Parenteral routes IV drug abusers 14 to 56 days Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. Fecal 15 contamination of food and water to 64 days Clinical Self course resembles HAV limiting, resolves on own Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. Liver enzymes AST ALT Alk Phosphatase Bilirubin IgM antibodies IgG antibodies HBsAg Anti-HBcAg IgM Anti-HDV Anti-HEV Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. Liver biopsy Stage and grading Percutaneous CT procedure guided imagery Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. Interventions Rest the liver Promote cellular regeneration Prevent complications High calorie, carbohydrates Supplemental vitamins Small, frequent meals Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. Medications Tenofovir – first line therapy Interferon – first line therapy Adefovir dipivoxil – second line therapy Lamivudine (Epivir-HBV) Telbivudine (Tyzeka) Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. A 55-year-old patient with a history of alcohol abuse spanning 10 years has been diagnosed with cirrhosis. The patient will be undergoing abdominal paracentesis on the medical unit today. Which assessment finding would alert the nurse that the paracentesis has been successful? A. Substantial decrease in blood pressure B. Decrease in post-procedure weight C. No residual obtained during procedure D. Immediate sensation of a need to urinate Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. (cont’d) The patient’s assessment reveals yellowish coloration of skin and sclerae. Which laboratory values would the nurse expect to find with this patient? A. Increased direct bilirubin, decreased indirect bilirubin B. Decreased direct bilirubin, increased indirect bilirubin C. Increased direct bilirubin, increased indirect bilirubin D. Increased urine bilirubin, decreased direct bilirubin Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. (cont’d) When a complete assessment of this patient is performed, what other manifestations would the nurse expect? (Select all that apply.) A. Ecchymosis B. Spider angiomas C. Personality changes D. Peripheral dependent edema E. Muscle twitching F. Dry skin with rash Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. (cont’d) The patient tells the nurse that once he is discharged to home, he has no intention to stop drinking alcohol. Which is the appropriate nursing response? A. “Why do you continue to drink?” B. “Does it frighten you to consider quitting?” C. “It’s your choice to drink or not to drink.” D. “If you continue to drink, you are going to die.” Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. 22 Which assessment parameter requires immediate intervention in a patient with severe ascites? A. B. C. D. Shallow respirations, rate 32 breaths/min Temperature 38.2° C Confusion Tachycardia, rate 110 beats/min Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. What is the priority intervention in the management of a patient with decompensated cirrhosis? A. B. C. D. Limiting protein intake Monitoring fluid intake and output Managing nausea and vomiting Elevating the head of bed >30 degrees Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc. What is a primary reason for a higher incidence of liver cancer in the United States? A. B. C. D. Incidence of illicit drug use Rising obesity Incidence of hepatitis C Increased Asian population Copyright © 2013, 2010, 2006, 2002 by Saunders, an imprint of Elsevier Inc.